Lyne Villeneuve

Quebec, QC G1V4G2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer.

Androgenic effects of 11-oxyandrogens in castration-resistant prostate cancer.

Journal: BMC cancer

Published: June 17, 2025

Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells.

Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells.

Journal: BMC cancer

Published: August 22, 2023

Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.

Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.

Journal: Clinical and translational medicine

Published: May 11, 2023

A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.

A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.

Journal: Cells

Published: March 28, 2023

The Glycosyltransferase Pathway: An Integrated Analysis of the Cell Metabolome.

The Glycosyltransferase Pathway: An Integrated Analysis of the Cell Metabolome.

Journal: Metabolites

Published: September 21, 2022

UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.

UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.

Journal: Cancer letters

Published: July 21, 2022

DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy.

DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy.

Journal: The Prostate

Published: December 17, 2019

Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients.

Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients.

Journal: Pharmacogenomics

Published: November 09, 2019

UGT2B17 modifies drug response in chronic lymphocytic leukaemia.

UGT2B17 modifies drug response in chronic lymphocytic leukaemia.

Journal: British journal of cancer

Published: August 08, 2019

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.

Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.

Journal: British journal of cancer

Published: August 05, 2019

Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.

Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: June 07, 2019

Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia.

Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia.

Journal: Frontiers in oncology

Published: March 29, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026